Category: Pharma Industry

Head of Drug Industry-Funded Think Tank Backs J&J’s Proposed Rebate Model, Slams Hospitals in Op-Ed

October 10, 2024 Shannon Young, Associate Editor/Senior Writer Views

Sally Pipes, the president and CEO of the drug-industry funded Pacific Research Institute, criticized pushback that led Johnson & Johnson to forgo its plans to implement a 340B rebate model in an Oct. 7 Forbes op-ed.

The leader of a right-leaning think tank that’s received funding from the drug industry criticized pushback that led Johnson & [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

CMS’ MDRP Final Rule May Impact 340B Covered Drugs, Attorneys Say

October 8, 2024 William Newton, Associate Editor/Senior Writer Views

CMS' recently-released MDRP final rule may affect 340B covered drugs and draw litigation.

A new federal regulation updating the definition of a covered outpatient drug could change the number of drugs covered under [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

GSK Announces Specialty Pharmacy Senderra No Longer Eligible to Dispense Asthma Drug

October 8, 2024 Bella Czajkowski, National Correspondent Views

Senderra Rx will no longer dispense GlaxoSmithKline’s asthma drug, Nucala.

Specialty pharmacy Senderra Rx will no longer dispense GlaxoSmithKline’s (GSK’s) asthma treatment Nucala, the drug manufacturer announced on industry vendor [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Amgen Announces NDC Change for Osteoporosis Drug

October 8, 2024 Bella Czajkowski, National Correspondent Views

Amgen announced a change to the national drug code for its osteoporosis drug, Prolia.

Drugmaker Amgen announced a change to the national drug code (NDC) for its osteoporosis drug, Prolia. The California-based drug giant [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Arkansas Begins Enforcement Against AstraZeneca for Allegedly Violating Contract Pharmacy Access Law

October 3, 2024 William Newton, Associate Editor/Senior Writer Views

The Arkansas Insurance Department held a preliminary hearing with attorneys for AstraZeneca on Oct. 1.

Arkansas officials initiated enforcement proceedings earlier this week against AstraZeneca for allegedly violating a state law that prohibits drugmaker 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

CMS Finalizes Next Medicare Drug Negotiation Guidance Without Resolving Key Concerns of 340B Stakeholders

October 3, 2024 William Newton, Associate Editor/Senior Writer Views

The AHA raised concerns that October 2024 federal guidance on Medicare drug price negotiations may allow drugmakers to “wrongly justify fundamental changes to the 340B program.”

Federal regulators issued final guidance for the next round of Medicare drug price negotiations yesterday but did not propose remedies [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Provider Groups, Key Federal Lawmaker Praise HRSA for Pressuring J&J to Drop 340B Rebate Proposal

October 1, 2024 William Newton, Associate Editor/Senior Writer Views

U.S. Rep. Abigail Spanberger (D-Va.) and multiple 340B provider groups applauded HRSA for its response on J&J's 340B rebate proposal.

Multiple 340B provider groups have applauded the federal government for threatening “strong” enforcement actions that led Johnson & Johnson (J&J) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Kalderos Launches New Drug Discount Platform with 340B Rebate Capabilities as Lawsuit with HHS Remains Paused

October 1, 2024 William Newton, Associate Editor/Senior Writer Views

Kalderos announced a new drug discount platform that supports 340B rebate capabilities.

Drug industry vendor Kalderos last week launched a new drug discount platform with 340B rebate capabilities as its prior lawsuit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

J&J Abandons 340B Rebate Due to HRSA’s Enforcement Threats But Defends Model in Letter to Agency

September 30, 2024 William Newton, Associate Editor/Senior Writer Views

J&J announced it will "forgo implementation" of its 340B rebate proposal due to enforcement threats from HRSA.

Johnson & Johnson (J&J) notified the Health Resources and Services Administration (HRSA) this morning that it will drop its 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

188 Bipartisan House Members Urge HHS Action Against J&J’s ‘Unlawful’ 340B Rebate Proposal

September 27, 2024 William Newton, Associate Editor/Senior Writer Views

A bipartisan group of 188 House members sent HHS a letter urging action against J&J's 340B rebate proposal.

A bipartisan group of 188 House lawmakers urged the federal government Friday to “use every enforcement tool” at its disposal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Category: Pharma Industry

Head of Drug Industry-Funded Think Tank Backs J&J’s Proposed Rebate Model, Slams Hospitals in Op-Ed

Please Login or Become a Paid Subscriber to View this Content

If you are already a

CMS’ MDRP Final Rule May Impact 340B Covered Drugs, Attorneys Say

Please Login or Become a Paid Subscriber to View this Content

If you are already a

GSK Announces Specialty Pharmacy Senderra No Longer Eligible to Dispense Asthma Drug

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Amgen Announces NDC Change for Osteoporosis Drug

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Arkansas Begins Enforcement Against AstraZeneca for Allegedly Violating Contract Pharmacy Access Law

Please Login or Become a Paid Subscriber to View this Content

If you are already a

CMS Finalizes Next Medicare Drug Negotiation Guidance Without Resolving Key Concerns of 340B Stakeholders

Please Login or Become a Paid Subscriber to View this Content

If you are already a

340B Provider Groups, Key Federal Lawmaker Praise HRSA for Pressuring J&J to Drop 340B Rebate Proposal

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Kalderos Launches New Drug Discount Platform with 340B Rebate Capabilities as Lawsuit with HHS Remains Paused

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Breaking News

J&J Abandons 340B Rebate Due to HRSA’s Enforcement Threats But Defends Model in Letter to Agency

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Breaking News

188 Bipartisan House Members Urge HHS Action Against J&J’s ‘Unlawful’ 340B Rebate Proposal

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Breaking News

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Breaking News

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live